• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转录组分析揭示了甲状腺癌患者肿瘤旁正常甲状腺组织中失调的基因。

Transcriptome analysis discloses dysregulated genes in normal appearing tumor-adjacent thyroid tissues from patients with papillary thyroid carcinoma.

机构信息

Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, 43210, USA.

The Ohio State University Comprehensive Cancer Center, The Ohio State University, McCampbell Hall South Room 565, 1581 Dodd Drive, Columbus, OH, 43210, USA.

出版信息

Sci Rep. 2021 Jul 8;11(1):14126. doi: 10.1038/s41598-021-93526-9.

DOI:10.1038/s41598-021-93526-9
PMID:34238982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8266864/
Abstract

Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. The molecular characteristics of histologically normal appearing tissue adjacent to the tumor (NAT) from PTC patients are not well characterized. The aim of this study was to characterize the global gene expression profile of NAT and compare it with those of normal and tumor thyroid tissues. We performed total RNA sequencing with fresh frozen thyroid tissues from a cohort of three categories of samples including NAT, normal thyroid (N), and PTC tumor (T). Transcriptome analysis shows that NAT presents a unique gene expression profile, which was not associated with sex or the presence of lymphocytic thyroiditis. Among the differentially expressed genes (DEGs) of NAT vs N, 256 coding genes and 5 noncoding genes have been reported as cancer genes involved in cell proliferation, apoptosis, and/or tumorigenesis. Bioinformatics analysis with Ingenuity Pathway Analysis software revealed that "Cancer, Organismal Injury and Abnormalities, Cellular Response to Therapeutics, and Cellular Movement" were major dysregulated pathways in the NAT tissues. This study provides improved insight into the complexity of gene expression changes in the thyroid glands of patients with PTC.

摘要

甲状腺乳头状癌 (PTC) 是最常见的甲状腺癌类型。PTC 患者肿瘤旁组织(NAT)的组织学正常外观的分子特征尚未得到很好的描述。本研究旨在描述 NAT 的全基因表达谱,并将其与正常和肿瘤甲状腺组织进行比较。我们使用来自三个样本类别(NAT、正常甲状腺 (N) 和 PTC 肿瘤 (T))的新鲜冷冻甲状腺组织进行了总 RNA 测序。转录组分析表明,NAT 呈现出独特的基因表达谱,与性别或淋巴细胞性甲状腺炎无关。在 NAT 与 N 之间差异表达的基因 (DEGs) 中,已有 256 个编码基因和 5 个非编码基因被报道为参与细胞增殖、凋亡和/或肿瘤发生的癌症基因。使用 Ingenuity Pathway Analysis 软件进行的生物信息学分析表明,“癌症、机体损伤和异常、细胞对治疗的反应和细胞运动”是 NAT 组织中主要失调的途径。这项研究提供了对 PTC 患者甲状腺中基因表达变化复杂性的深入了解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de4/8266864/936b4d602629/41598_2021_93526_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de4/8266864/93c75b3fdbbf/41598_2021_93526_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de4/8266864/8cd458ee0feb/41598_2021_93526_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de4/8266864/6b99fe0ffc3f/41598_2021_93526_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de4/8266864/81729bf30f88/41598_2021_93526_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de4/8266864/936b4d602629/41598_2021_93526_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de4/8266864/93c75b3fdbbf/41598_2021_93526_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de4/8266864/8cd458ee0feb/41598_2021_93526_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de4/8266864/6b99fe0ffc3f/41598_2021_93526_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de4/8266864/81729bf30f88/41598_2021_93526_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7de4/8266864/936b4d602629/41598_2021_93526_Fig5_HTML.jpg

相似文献

1
Transcriptome analysis discloses dysregulated genes in normal appearing tumor-adjacent thyroid tissues from patients with papillary thyroid carcinoma.转录组分析揭示了甲状腺癌患者肿瘤旁正常甲状腺组织中失调的基因。
Sci Rep. 2021 Jul 8;11(1):14126. doi: 10.1038/s41598-021-93526-9.
2
Overexpression of novel long intergenic non‑coding RNA LINC02454 is associated with a poor prognosis in papillary thyroid cancer.新型长链非编码 RNA LINC02454 的过表达与甲状腺乳头状癌的不良预后相关。
Oncol Rep. 2020 Oct;44(4):1489-1501. doi: 10.3892/or.2020.7712. Epub 2020 Aug 3.
3
lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.长链非编码 RNA DUXAP8 通过海绵吸附 miR-20b-5p/SOS1 轴抑制甲状腺乳头状癌细胞凋亡。
Oncol Rep. 2021 May;45(5). doi: 10.3892/or.2021.8015. Epub 2021 Mar 24.
4
Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysis.整合生物信息学分析鉴定甲状腺乳头状癌的关键基因。
Biosci Rep. 2020 Aug 28;40(8). doi: 10.1042/BSR20201555.
5
Role of differentially expressed genes and long non-coding RNAs in papillary thyroid carcinoma diagnosis, progression, and prognosis.差异表达基因和长非编码 RNA 在甲状腺乳头状癌诊断、进展和预后中的作用。
J Cell Biochem. 2018 Nov;119(10):8249-8259. doi: 10.1002/jcb.26836. Epub 2018 Jul 3.
6
Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis.Hsa_circ_0058124 通过 NOTCH3/GATAD2A 轴促进甲状腺乳头状癌细胞的发生和侵袭。
J Exp Clin Cancer Res. 2019 Jul 19;38(1):318. doi: 10.1186/s13046-019-1321-x.
7
Comprehensive transcriptomic analysis of papillary thyroid cancer: potential biomarkers associated with tumor progression.甲状腺乳头癌的综合转录组分析:与肿瘤进展相关的潜在生物标志物。
J Endocrinol Invest. 2020 Jul;43(7):911-923. doi: 10.1007/s40618-019-01175-7. Epub 2020 Jan 21.
8
Genome-Wide Expression Screening Discloses Long Noncoding RNAs Involved in Thyroid Carcinogenesis.全基因组表达筛选揭示参与甲状腺癌发生的长链非编码RNA
J Clin Endocrinol Metab. 2016 Nov;101(11):4005-4013. doi: 10.1210/jc.2016-1991. Epub 2016 Jul 26.
9
MYC promotes the development of papillary thyroid carcinoma by inhibiting the expression of lncRNA PAX8‑AS1:28.MYC 通过抑制长链非编码 RNA PAX8-AS1:28 的表达促进甲状腺乳头状癌的发展。
Oncol Rep. 2019 Apr;41(4):2511-2517. doi: 10.3892/or.2019.6996. Epub 2019 Feb 1.
10
LncRNA CASC15 promotes the proliferation of papillary thyroid carcinoma cells by regulating the miR-7151-5p/WNT7A axis.长链非编码RNA CASC15通过调控miR-7151-5p/WNT7A轴促进甲状腺乳头状癌细胞的增殖。
Pathol Res Pract. 2021 Sep;225:153561. doi: 10.1016/j.prp.2021.153561. Epub 2021 Jul 21.

引用本文的文献

1
METTL1-mediated mG tRNA modification drives papillary thyroid cancer progression and metastasis by regulating the codon-specific translation of TNF-α.METTL1介导的mG tRNA修饰通过调节TNF-α的密码子特异性翻译驱动甲状腺乳头状癌的进展和转移。
Cell Death Dis. 2025 May 14;16(1):378. doi: 10.1038/s41419-025-07716-8.
2
Identification and validation of the common pathogenesis and hub biomarkers in Papillary thyroid carcinoma complicated by rheumatoid arthritis.甲状腺乳头状癌合并类风湿关节炎的共同发病机制及核心生物标志物的鉴定与验证
PLoS One. 2025 Mar 10;20(3):e0317369. doi: 10.1371/journal.pone.0317369. eCollection 2025.
3

本文引用的文献

1
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
2
Non-Coding RNAs: Uncharted Mediators of Thyroid Cancer Pathogenesis.非编码RNA:甲状腺癌发病机制中未知的调节因子
Cancers (Basel). 2020 Nov 4;12(11):3264. doi: 10.3390/cancers12113264.
3
Non-coding RNA in thyroid cancer - Functions and mechanisms.甲状腺癌中的非编码 RNA-功能与机制。
Exploration of the prognostic value of methylation regulators related to m5C in papillary thyroid carcinoma.
探索与 m5C 相关的甲基化调节剂在甲状腺乳头状癌中的预后价值。
Medicine (Baltimore). 2024 Jun 21;103(25):e38623. doi: 10.1097/MD.0000000000038623.
4
A Comprehensive Analysis of the Effect of A>I(G) RNA-Editing Sites on Genotoxic Drug Response and Progression in Breast Cancer.A>I(G) RNA编辑位点对乳腺癌基因毒性药物反应及进展影响的综合分析
Biomedicines. 2024 Mar 25;12(4):728. doi: 10.3390/biomedicines12040728.
5
Long non-coding RNA ACTA2-AS1 suppresses metastasis of papillary thyroid cancer via regulation of miR-4428/KLF9 axis.长链非编码 RNA ACTA2-AS1 通过调控 miR-4428/KLF9 轴抑制甲状腺乳头状癌细胞的转移。
Clin Epigenetics. 2024 Jan 9;16(1):10. doi: 10.1186/s13148-023-01622-6.
6
Gene Variants Predisposing to Papillary Thyroid Cancer.易患甲状腺乳头状癌的基因变异
Thyroid. 2024 May;34(5):575-582. doi: 10.1089/thy.2023.0560. Epub 2024 Jan 10.
7
circAGTPBP1 promotes the progression of papillary thyroid cancer through the notch pathway via the miR-34a-5p/notch1 axis.环状AGTPBP1通过miR-34a-5p/Notch1轴经Notch信号通路促进甲状腺乳头状癌进展。
iScience. 2023 Aug 9;26(9):107564. doi: 10.1016/j.isci.2023.107564. eCollection 2023 Sep 15.
8
Advances in transcriptomics and proteomics in differentiated thyroid cancer: An updated perspective (Review).分化型甲状腺癌的转录组学和蛋白质组学进展:最新观点(综述)
Oncol Lett. 2023 Jul 27;26(3):396. doi: 10.3892/ol.2023.13982. eCollection 2023 Sep.
9
Characterization of Lactate Metabolism Score in Breast and Thyroid Cancers to Assist Immunotherapy via Large-Scale Transcriptomic Data Analysis.通过大规模转录组数据分析表征乳腺癌和甲状腺癌中的乳酸代谢评分以辅助免疫治疗
Front Pharmacol. 2022 Jul 7;13:928419. doi: 10.3389/fphar.2022.928419. eCollection 2022.
Cancer Lett. 2021 Jan 1;496:117-126. doi: 10.1016/j.canlet.2020.08.021. Epub 2020 Sep 16.
4
Gelsolin Promotes Cancer Progression by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma and Correlates with a Poor Prognosis.凝溶胶蛋白通过调节肝细胞癌上皮-间质转化促进癌症进展并与不良预后相关。
J Oncol. 2020 Jan 8;2020:1980368. doi: 10.1155/2020/1980368. eCollection 2020.
5
Impact of Overweight and Obesity on US Papillary Thyroid Cancer Incidence Trends (1995-2015).超重和肥胖对美国甲状腺乳头状癌发病率趋势的影响(1995-2015)。
J Natl Cancer Inst. 2020 Aug 1;112(8):810-817. doi: 10.1093/jnci/djz202.
6
Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype.基于图的基因组比对和基因分型与 HISAT2 和 HISAT-genotype。
Nat Biotechnol. 2019 Aug;37(8):907-915. doi: 10.1038/s41587-019-0201-4. Epub 2019 Aug 2.
7
Thyroid autoimmune disorders and cancer.甲状腺自身免疫性疾病与癌症。
Semin Cancer Biol. 2020 Aug;64:135-146. doi: 10.1016/j.semcancer.2019.05.019. Epub 2019 May 31.
8
Association between Hashimoto's thyroiditis and papillary thyroid carcinoma: a retrospective analysis of 305 patients.桥本甲状腺炎与甲状腺乳头状癌的相关性:305 例患者的回顾性分析。
BMC Endocr Disord. 2019 May 29;19(Suppl 1):26. doi: 10.1186/s12902-019-0351-x.
9
Structure, regulation and related diseases of the actin-binding protein gelsolin.肌动蛋白结合蛋白gelsolin 的结构、调节及相关疾病。
Expert Rev Mol Med. 2019 Jan 30;20:e7. doi: 10.1017/erm.2018.7.
10
Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer.长链非编码RNA与微小RNA在癌症中的相互作用
Methods Mol Biol. 2018;1819:75-92. doi: 10.1007/978-1-4939-8618-7_4.